{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:51:48Z","timestamp":1773237108397,"version":"3.50.1"},"reference-count":50,"publisher":"Kurume Medical Journal","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kurume Med. J."],"published-print":{"date-parts":[[2021,6,30]]},"DOI":"10.2739\/kurumemedj.ms682018","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T22:16:28Z","timestamp":1683843388000},"page":"63-68","source":"Crossref","is-referenced-by-count":2,"title":["Correlation of Celiac Diseases with <i>Candida<\/i> Spp. Based on Anti-gliadin Antibodies"],"prefix":"10.2739","volume":"68","author":[{"given":"ALI ABDUL HUSSEIN S.","family":"AL-JANABI","sequence":"first","affiliation":[{"name":"Department of Microbiology, College of Medicine, University of Karbala"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAITHAM JASSIM","family":"MOHAMMED","sequence":"additional","affiliation":[{"name":"Department of Microbiology, College of Medicine, University of Karbala"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1445","reference":[{"key":"1","unstructured":"1. Hameed AR, Ali SM, and Ahmed LT. Biological study of Candida species and virulence factor. International J Advanced Research in Engineering & Technology 2018; 1:8-16."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. McCullough MJ, Ross BC, and Reade PC. Candida albicans: a review of its history, taxonomy, epidemiology, virulence attributes, and methods of strain differentiation. Int J Oral Maxillofac Surg 1996; 25:136-144.","DOI":"10.1016\/S0901-5027(96)80060-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kobayashi SD and Cutler JE. Candida albicans hyphal formation and virulence: is there a clearly defined role? Trends Microbiol 1998; 6:92-94.","DOI":"10.1016\/S0966-842X(98)01218-9"},{"key":"4","unstructured":"4. Surain P and Aggarwal NK. CANDIDA, A HUMAN PATHOGEN AND MAJOR TYPES OF CANDIDIASIS. International J Pharmaceutical Sciences and Research 2020; 11:41-67."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Turner SA and Butler G. The Candida Pathogenic Species Complex. Cold Spring Herb Perspect Med 2014; 4:a019778.","DOI":"10.1101\/cshperspect.a019778"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 2005; 128:S68-S73.","DOI":"10.1053\/j.gastro.2005.02.015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bizzaro N, Tonutti E, and Villalta D. Antigliadin and antideamidated gliadin peptide antibodies. Autoantibodies 2014; 3:471-476.","DOI":"10.1016\/B978-0-444-56378-1.00055-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sharma N, Bhatia S, Chunduri V, Kaur S, Sharma S et al. Pathogenesis of celiac disease and other gluten related disorders in wheat and strategies for mitigating them. Front Nutr 2020; 7:6.","DOI":"10.3389\/fnut.2020.00006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Silano M, Vincentini O, and De Vincenzi M. Toxic, immunostimulatory and antagonist gluten peptides in celiac disease. Curr Med Chem 2009; 16:1489-1498.","DOI":"10.2174\/092986709787909613"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Biesieekierski JR. What is gluten?. J Gastroenterology and Hepatology 2017; 32:78-81.","DOI":"10.1111\/jgh.13703"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Elzoghby AO, Elgohary MM, and Kamel NM. Implications of protein and peptide-based nanoparticles as potential vehicles for anticancer drugs. Adv Protein Chem Struct Biol 2015; 98:169-221.","DOI":"10.1016\/bs.apcsb.2014.12.002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Brusca I. Overview of biomarkers for diagnosis and monitoring of celiac disease. Adv Clin Chem 2015; 68:1-55.","DOI":"10.1016\/bs.acc.2014.12.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Qi PF, Wei YM, Yue YW, Yan ZH, and Zheng YL. Biochemical and molecular characterization of gliadins. Molecular Biology 2006; 40:769-807.","DOI":"10.1134\/S0026893306050050"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Korponay-Szab\u00f3 lR, Troncone R, and Discepolo V. Adaptive diagnosis of coeliac disease. Best Pract Res Clin Gastroenterol 2015; 29:381-398.","DOI":"10.1016\/j.bpg.2015.05.003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hill PG and McMillan SA. Anti-tissue transglutaminase antibodies and their role in the investigation of coeliac disease. Ann Clin Biochem 2006; 43:105-117.","DOI":"10.1258\/000456306776021599"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Aaron L and Torsten M. Candida albicans in celiac disease: A wolf in sheep\u2019s clothing. Autoimmun Rev 2020; 19:102621.","DOI":"10.1016\/j.autrev.2020.102621"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Renga G, Bellet MM, Stincardini C, Pariano M, Oikonomou V et al. To Be or Not to Be a Pathogen: Candida albicans and Celiac Disease. Front Immunol 2019; 10:2844.","DOI":"10.3389\/fimmu.2019.02844"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nieuwenhuizen WF, Pieters RH, Knippels LM, Jansen MC, and Koppelman SJ. Is Candida albicans a trigger in the onset of coeliac disease? Lancet 2003; 361:2152-2154.","DOI":"10.1016\/S0140-6736(03)13695-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Harnett J, Myers SP, and Rolfe M. Significantly higher faecal counts of the yeasts Candida and Saccharomyces identified in people with coeliac disease. Gut Pathog 2017; 9:26.","DOI":"10.1186\/s13099-017-0173-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bouroumane MR, Louhab N, Benhiba I, Amine M, Kissani N et al. Anti-gliadin antibodies and gluten neuropathies: a borderline link. Br J Med Med Res 2016; 11:1-10.","DOI":"10.9734\/BJMMR\/2016\/21929"},{"key":"21","unstructured":"21. Kamaeva OI, Renznikov IP, Pimenova NS, and Dobritsyna LV. Antigliadin antibodies in the absence of celiac disease. Klin Med (Mosk) 1998; 76:33-35."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kolchak NA, Tetranikova MK, Theodoropoulou MS, Michalopoulou AP, Theodoropoulos DS. Prevalence of antigliadin IgA antibodies in psoriasis vulgaris and response of seropositive patients to a gluten-free diet. J Multidiscip Healthc 2018; 11:13-19.","DOI":"10.2147\/JMDH.S122256"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Castillo-Ortiz JD, Dur\u00e1n-Barrag\u00e1n S, S\u00e1nchez-Ort\u00edz A, and Ramos-Remus C. Anti-transglutaminase, antigliadin and ultra purified anti-gliadin antibodies in patients with a diagnosis of rheumatoid arthritis. Reumatol CI\u00edn 2011; 7:27-29.","DOI":"10.1016\/j.reuma.2010.03.006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Jin S, Wu N, Xu Q, Zhang X, Ju G et al. A study of circulating gliadin antibodies in schizophrenia among a Chinese population. Schizophrenia Bulletin 2012; 38:514-518.","DOI":"10.1093\/schbul\/sbq111"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Garcia YH, D\u00edez SG, Aizp\u00fan LT, and Oliva NP. Antigliadin antibodies associated with chronic mucocutaneous candidiasis. Pediatr Dermatol 2002; 19:415-418.","DOI":"10.1046\/j.1525-1470.2002.00117.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Brinkert F, Somsakrin M, Krebs-Schmitt D, and Ganschow R. Chronic mucocutaneous candidiasis may cause elevated gliadin antibodies. ACTA Paediatr 2009; 98:1685-1688.","DOI":"10.1111\/j.1651-2227.2009.01350.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. d\u02bcEnfert C, Kaune A, Alaban L, Chakraborty S, Cole N et al. The impact of the fungus-host-microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev 2020; 45:fuaa060.","DOI":"10.1093\/femsre\/fuaa060"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Moris DV, Melhem MS, Martins MA, and Mendes RP. Oral Candida spp. colonization in human immunodeficiency virus-infected individuals. J Venom Anim Roxins incl Trop Dis 2008; 14:224-257.","DOI":"10.1590\/S1678-91992008000200004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nardecchia S, Auricchio R, Discepolo V, and Troncone R. Extra-intestinal manifestations of coeliac disease in children: clinical features and mechanisms. Front Pediatr 2019; 7:56.","DOI":"10.3389\/fped.2019.00056"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Caio G, Volta U, Sapone A, Leffler DA, Giorgio RD et al. Celiac disease: a comprehensive current review. BMC Medicine 2019; 17:142.","DOI":"10.1186\/s12916-019-1380-z"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Akobeng AK and Thomas AG. Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Ther 2008; 27:1044-1052.","DOI":"10.1111\/j.1365-2036.2008.03669.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Shan L, Molberg \u00d8, Parrot I, Hausch F, Filiz F et al. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297:2275-2279.","DOI":"10.1126\/science.1074129"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Barone MV, Troncone R, and Auricchio S. Gliadin peptides as triggers of the proliferative and stress\/innate immune response of the celiac small intestinal mucosa. Int J Mol Sci 2014; 15:20518-20537.","DOI":"10.3390\/ijms151120518"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Green PH, Rostami K, and Marsh MN. Diagnosis of coeliac disease. Best Pract Res Clin Gastroenterol 2005; 19:389-400.","DOI":"10.1016\/j.bpg.2005.02.006"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Reif S and Lerner A. Tissue transglutaminase--the key player in celiac disease: a review. Autoimmun Rev 2004; 3:40-45.","DOI":"10.1016\/S1568-9972(03)00065-X"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Rauhavirta T, Hietikko M, Salmi T, and Lindfors K. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review. Clin Rev Allergy Immunol 2019; 57:23-38.","DOI":"10.1007\/s12016-016-8557-4"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Huebener S, Tanaka CK, Uhde M, Zone JJ, Vensel WH et al. Specific non-gluten proteins of wheat are novel target antigens in celiac disease humoral response. J Proteome Res 2015; 14:503-511.","DOI":"10.1021\/pr500809b"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ciccocioppo R, Sabatino AD, Ara C, Biagi F, Perilli M et al. Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Clin Exp Immunol 2003; 134:516-524.","DOI":"10.1111\/j.1365-2249.2003.02326.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Ashorn S, V\u00e4lineva T, Kaukinen K, Ashorn M, Braun J et al. Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J Clin Immunol 2009; 29:190-195.","DOI":"10.1007\/s10875-008-9255-7"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Corouge M, Loridant S, Fradin C, Salleron J, Damines S et al. Humoral immunity links Candida albicans infection and celiac disease. PLoS ONE 2015; 10:e0121776.","DOI":"10.1371\/journal.pone.0121776"},{"key":"41","unstructured":"41. Boutrid N, Amrane M, and Rahmoune H. The yeast behind the sprue: is it true? Eur Rev Med Pharmacol Sci 2019; 23:10182-10183."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Ruiz-Herrera J, Iranzo M, Elorza MV, Sentandreu R, Mormeneo S. Involvement of transglutaminase in the formation of covalent cross-links in the cell wall of Candida albicans. Arch Microbiol 1995; 164:186-193.","DOI":"10.1007\/BF02529970"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 1999; 283:1535-1538.","DOI":"10.1126\/science.283.5407.1535"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Ponniah G, Rollenhagen C, Bahn Y, Staab JF, and Sundstrom P. State of differentiation defines buccal epithelial cell affinity for cross-linking to Candida albicans Hwp1. J Oral Pathol Med 2007; 36:456-467.","DOI":"10.1111\/j.1600-0714.2007.00565.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Hill PG, Thompson SP, and Holmes KT. IgA anti-gliadin antibodies in adult celiac disease. Clin Chem 1991; 37:647-650.","DOI":"10.1093\/clinchem\/37.5.647"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Kelly CP, Feighery CF, Gallagher RB, Gibney MJ, and Weir DG. Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Dig Dis Sci 1991; 36:743-751.","DOI":"10.1007\/BF01311231"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Bahia M, Rabello A, Filho GB, and Penna FJ. Serum antigliadin antibody levels as a screening criterion before jejuna biopsy indication for celiac disease in a developing country. Braz J Med Biol Res 2001; 34:1415-1420.","DOI":"10.1590\/S0100-879X2001001100007"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Rostom A, Dub\u00e9 C, Cranney A, Saloojee M, Sy R et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128:S38-S46.","DOI":"10.1053\/j.gastro.2005.02.028"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Rashtak S, Ettore MW, Homburger HA, and Murray JA. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol 2008; 6:426-432.","DOI":"10.1016\/j.cgh.2007.12.030"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Ortiz M, Fragoso A, and O\u02bcSullivan CK. Detection of antigliadin autoantibodies in celiac patient samples using a cyclodextrin-based supramolecular biosensor. Anal Chem 2011; 83:2931-2938.","DOI":"10.1021\/ac102956p"}],"container-title":["The Kurume Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/68\/2\/68_MS682018\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T04:45:33Z","timestamp":1688791533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/68\/2\/68_MS682018\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2739\/kurumemedj.ms682018","relation":{},"ISSN":["0023-5679","1881-2090"],"issn-type":[{"value":"0023-5679","type":"print"},{"value":"1881-2090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,30]]},"article-number":"MS682018"}}